The IQVIA Podcast: Recent Episodes
IQVIA
The pace of change in healthcare is accelerating. Our understanding of how data, technology and scientific expertise can come together is only getting more precise. In this podcast, leaders from IQVIA lead discussions on the issues, innovations, and collaborations that are making an impact on health and business outcomes. Topics will include new approaches to clinical development, leading-edge technologies and methodologies that extract more value (and less work) from healthcare data, and strategies that ensure the right medicines get to the right patients, faster. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare - and human health - forward.
In this episode of Healthcare Talks, we explore the real-world experiences of patients using obesity medications, including GLP-1 treatments, in Belgium. Beyond the headlines, we discuss treatment adherence, side effects, costs, and the behavioral factors that influence long-term success. Join us as we uncover the gap between clinical expectations and everyday patient reality, and the important role healthcare professionals play throughout the journey.
In this episode of the IQVIA MedTech Business Insights Podcast, Michelle Edwards speaks with Arvind Ramadore, Global Head of Innovations for Robotic Surgery Technologies at Medtronic, to discuss how robotics and AI are reshaping the future of surgery.
Their conversation explores the opportunities and challenges facing the industry, from evidence generation and reimbursement to regulation, digital ecosystems and the path toward greater surgical autonomy.
This episode explores how pharmaceutical engagement will evolve as AI increasingly becomes the first port of call for HCPs to access medical information and guidelines. Learn how investments must shift as share of algorithmic trust becomes a key battleground, and how in-field roles will need to evolve to provide deeper, more consultative engagements.
In this episode of the IQVIA podcast, Daniel Mora-Brito, Engagement Manager, Global Health, Thought Leadership, examines the growing urgency of addressing obesity as a central driver of noncommunicable diseases (NCDs), particularly in low- and middle-income countries (LMICs) and what is at stake if action is delayed. Joined by Johanna Ralston, CEO, World Obesity Federation; Claudia Martínez, Director of Research, Access to Medicine Foundation; and Helen McGuire, Global Lead, NCDs, PATH, the discussion explores how governments and global institutions can elevate obesity within national and global NCD agendas through stronger advocacy, policy prioritization, prevention, and system level responses. The conversation also unpacks the evolving role of treatment and innovation and outlines the concrete steps needed to ensure access is equitable, sustainable, and aligned with long term public health goals.
Enjoyed this content? Check out out white paper "Expanding the toolbox for obesity prevention and treatment in low- and middle-income countries: What does it take to make it happen?" for further insights.
Artificial Intelligence (AI) is no longer a futuristic concept in life sciences—it’s here, transforming drug safety and pharmacovigilance at an unprecedented pace. But as the industry embraces automation and advanced analytics, one truth stands firm: innovation without governance is a risk no one can afford.
In this episode of The Top Line, we explore how AI is reshaping drug safety while governance sets the guardrails for ethical, compliant, and sustainable adoption. Our featured guest, Marie Flanagan, Regulatory and AI Governance Lead at IQVIA Safety Technologies, dives deep into why governance isn’t just a checkbox—it’s the backbone of responsible AI deployment in healthcare.
Key Themes You’ll Discover:
The Dual Imperative: Innovation and OversightAI promises speed, accuracy, and scalability in pharmacovigilance, from case intake to signal detection. Yet, without robust governance frameworks, these benefits can quickly turn into liabilities. Learn why embedding governance into AI design from day one is critical—and why retrofitting controls later is a recipe for risk.
Shared Responsibility Across StakeholdersGovernance isn’t the job of one team. Flanagan explains how compliance, technology, business units, and regulators must collaborate to ensure AI systems are ethically designed, technically validated, and transparent. Discover how this multi-layered approach builds trust and resilience in a rapidly evolving regulatory landscape.
Principles That Matter: Human Oversight, Fairness, AccountabilityFrom mitigating bias to ensuring explainability, guiding principles are more than buzzwords—they’re operational necessities. We unpack how these principles translate into practical steps, including continuous monitoring, feedback loops, and adaptive controls that evolve with technology.
Compliance as an Enabler, Not a BarrierTraditionally seen as a brake on innovation, compliance teams can become catalysts for safe progress. Hear how organizations are reframing compliance roles to support innovation while safeguarding patient safety and regulatory integrity.
Global Regulatory ContextWith frameworks like the EU AI Act and U.S. federal memoranda shaping expectations, companies must navigate a complex web of international standards. Flanagan shares insights on harmonizing governance strategies across jurisdictions without slowing down innovation.
Practical Playbook for Life SciencesFrom zero-touch case processing to agentic AI in signal workflows, we spotlight real-world use cases that demonstrate how governance and technology can coexist—and thrive. Learn how IQVIA’s Vigilance Platform integrates governance into every layer of AI-driven pharmacovigilance.
Why This Matters NowAI adoption in pharma is accelerating, with 85% of top companies prioritizing AI as a strategic imperative. But speed without structure can lead to compliance gaps, reputational damage, and patient risk. This episode equips you with the insights to innovate responsibly, ensuring your AI journey is both ambitious and anchored in governance.
Tune in for actionable strategies, expert perspectives, and a candid conversation on the future of drug safety in the AI era. Whether you’re a regulatory leader, technology strategist, or business decision-maker, this episode will help you balance the promise of AI with the principles that protect patients and preserve trust.
Join IQVIA Thought Leaders, Sarah Rickwood and Kirstie Scott as they discuss key changes in the launch environment. Hear about the rising importance of the private market (led by, but not limited to obesity medications) and how pharma must quickly adapt to AI-enabled HCP self-empowerment.
In this episode, Dr. Paul Beresford, Senior Vice President of Biopharma Partnerships at PathAI, shares perspectives on how artificial intelligence is transforming pathology workflows, enhancing diagnostic accuracy, and supporting precision medicine. Discover practical insights on AI integration, regulatory alignment, and the evolving partnership between technology and clinical expertise in diagnostics.
Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIA
Featured Speaker: Paul Beresford, Ph.D., Senior Vice President of Biopharma Partnerships, PathAI
In this episode, Stefan Lutzmayer, from IQVIA’s EMEA Thought Leadership team, speaks with Özgür Tuncer, CEO & Executive Director of Stablepharma, about the growing complexity of the pharmaceutical cold chain and how innovation could make it more resilient, sustainable, and accessible.
IQVIA’s EMEA Thought Leadership team analyses major trends shaping the pharmaceutical market and their implications for healthcare systems and companies across the region.
You’ll hear about:
- Why “keeping it cold” is more than logistics—it’s about safety, equity and sustainability.
- Where breakdowns happen in practice, from transport to site of administration.
- Why the cold chain is not just an issue of low- and middle-income countries.
- How hidden costs and emissions make the cold chain a big topic for healthcare systems around the world.
- The promise of thermostable technology to reduce waste, cut costs and expand access globally.
Listen in for practical insights on how the next decade of cold-chain innovation could reshape the future of biologics and global health.
For more insights, read IQVIA’s white paper “Tip of the Iceberg: Economic and Environmental Impact of the Vaccine Cold Chain.”
Welcome to “Debunking Value, Access & Pricing Myths”—a podcast series from IQVIA’s Value and Payer Evidence team where we explore the transformations underway in healthcare pricing and market access - challenging outdated norms and shedding light on the new realities shaping our work.
In the second episode, your host Rebecca Coady, Principal at IQVIA, is joined by her colleague Katrin Lamp. Together, they take on a myth “Pricing in Germany is always transparent.”
Katrin, who is a principal at IQVIA and an expert in the German market, shares her perspectives on the major changes to drug pricing in the largest EU pharmaceutical market, Germany, and what this means for pricing strategy development and price management – they cover what you need to know about the changing pricing rules, including the opportunity for confidential pricing.
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the importance of target product profiles, particularly when navigating funding challenges, with Ian Fisher, head of development analytics.
In this episode, BioSpace’s head of insights Lori Ellis discusses how AI transformation can help organizations navigate a rapidly evolving regulatory environment with senior director of regulatory innovation and technology, Michelle Gyzen.
In this episode, BioSpace’s head of insights Lori Ellis discusses the FDA’s first draft guidance for AI in drug development, published in January 2025, with Archana Hegde, Senior Director, PV systems and innovations at IQVIA.
In this episode, BioSpace’s head of insights Lori Ellis discusses the evolving role of local qualified persons for pharmacovigilance with Ana Pedro Jesuíno, global head local QPPV network at IQVIA.
In this episode, BioSpace’s head of insights Lori Ellis discusses the concerns and opportunities of patient data driving AI tasks with Louise Molloy, associate director medical information and pharmacovigilance.
This episode focuses on how Agentic AI is shaping the future of clinical research.
In this episode you will:
- Learn about the differences between an AI agent and an agentic framework and how the latter can coordinate and orchestrate many different AI agents to answer more complex questions.
- Explore the capabilities of Agentic AI and its applications in clinical trials and early clinical development.
- Hear how an Agentic AI framework provided a pharma company with a roadmap a decade out to see how to optimally develop their R&D pipeline for a therapeutic area of interest.
Greg Lever, Director of AI Solutions Delivery at IQVIA, is our featured guest.
Welcome to “Debunking Value, Access & Pricing Myths”—a podcast series from IQVIA’s Value and Payer Evidence team where we separate fact from fiction on some of the most persistent misconceptions in the world of healthcare pricing and access.
In this debut episode, your host Rebecca Coady, Principal at IQVIA, is joined by her colleague and EU HTA expert, Sian Tanner. Together, they take on a myth that's loomed large in the industry for decades: “A centralized EU HTA will never happen.”
Sian, who leads IQVIA’s EU HTA Solutions offering, unpacks what the reality of EU HTA implementation means for pharmaceutical teams across Europe.
From challenges and timelines to strategic priorities and long-term implications for market access, they cover what you need to know—and what your team should be doing now to prepare.
This episode focuses on how IQVIA is innovating with agentic AI to drive efficiency and quality in clinical trials.
In this episode you will:
- Discover how agentic AI can be leveraged to enhance efficiency and quality in clinical trials and help increase the chance of success.
- See how an agentic AI approach can optimize site selection, trial design, and other critical elements in clinical trials.
- Learn about using agentic AI to identify new indications and targets in early clinical development by analyzing data from multiple databases.
Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA’s Research and Development Solutions.
This podcast features malaria experts Caroline Boulton (Global Program Head, Malaria, at Novartis); Sherwin Charles (CEO, Goodbye Malaria); and Carlos Chaccour (Researcher and Visiting Scholar, Navarra Institute for International Development). The conversation delves into the current malaria response, examining shifts in international funding, R&D innovations, drug resistance challenges, emerging prevention tools, and the impact of climate change.
The podcast is hosted by IQVIA’s Daniel Mora-Brito, Engagement Manager, Global Health, EMEA Thought Leadership.
In this episode, IQVIA MedTech experts Michelle Edwards and Michaela Miller discuss key trends shaping the MedTech industry in 2025. The conversation covers advancements in 3D printing, real-world evidence (RWE), and clinical AI, among others.
Read Ten MedTech Trends to Watch in 2025 to learn more.
Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIA
Featured Speaker: Michelle Edwards, Practice Lead, U.S. MedTech Real World and Clinical Solutions, IQVIA
This podcast episode features a discussion between Jeff Pilch from IQVIA and Sanjay Mistry from Molnlycke. Together, they explore the journey of how their companies collaborated to solve a significant business problem related to customer master data management (MDM). Sanjay explains the challenges Molnlycke faced in defining and managing customer data across different units, which hindered their ability to perform basic analytics and customer segmentation. Jeff and Sanjay then discussed the solutions proposed by IQVIA, emphasizing a practical, incremental approach to implementing MDM and data governance, which helped Molnlycke achieve better data management and business efficiency.
Featured Speakers:
- Jeff Pilch - MDM Practice Lead, IQVIA
- Sanjay Mistry - Director Data Operations, Commercial Excellence at Molnlycke
On International HPV Awareness Day, Dr. Nicola Paul hosts Dr. Tando Gaqana, a passionate HPV vaccine advocate, and Daniel Mora-Brito, IQVIA's thought leader in global health, to discuss the impact of Human Papillomavirus (HPV) in South Africa, highlighting the importance of vaccination and regular screening to prevent HPV-related conditions in Africa.
This episode focuses on using AI for indication selection and prioritization to optimize the value of clinical development planning.
In this episode you will:
- Discover how AI can identify indications with the greatest probability of success and areas of untapped opportunity.
- See how AI can be leveraged to prioritize hundreds of indications into high-potential opportunities rapidly.
- Learn about using AI to look at clinical trial data to help predict the future competitive intensity for an indication.
Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA’s Research and Development Solutions.
In this episode, Ekra Yao shares his view of the ongoing efforts and strategies in the fight against polio in Africa.
In this episode, Dr. Vishakha Sharma, Senior Principal Data Scientist at Roche Diagnostics shares her perspectives on the potential of GenAI to improve patient outcomes, enhance the efficiency of healthcare delivery, and reduce costs. She also addresses some of the key issues surrounding data interoperability and data integration when dealing with diverse data sources and unstructured data. The discussion brings attention to the need for guiding principles and highlights the ethical frameworks.
Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIA
Featured Speaker: Vishakha Sharma, Ph.D., Senior Principal Data Scientist, Roche Diagnostics
Join IQVIA Thought Leaders, Kirstie Scott and Stefan Lutzmayer, to explore how to translate the promise of ground-breaking oncology therapies into commercially successful launches. Learn about the evolving oncology landscape, and how to navigate a fluid and challenging commercial environment to achieve Oncology Launch Excellence.
In this episode you will:
- Discover how AI can predict the success of clinical trials in terms of efficacy, regulatory approval, operational feasibility, reimbursement attainment and product uptake.
- Learn why AI can give us deeper insights by analyzing unstructured data for better-informed clinical development decisions.
- See how an agentic AI approach can speed up what would take months and weeks manually, to days and hours, while looking at even more information for the analysis.
Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA’s Research and Development Solutions
Tune in to the latest episode of the IQVIA SFE Insights Podcast as Lakshdeep Singh, Senior Principal at IQVIA, and Goksu Dogan, Senior Principal in the Artificial Intelligence and Machine Learning Solutions team, explore the role of predictive analytics and real-time triggers in optimizing HCP engagement and improving patient outcomes. Discover how AI/ML-powered solutions are revolutionizing the pharmaceutical industry and providing actionable insights that drive better business results. Don't miss this insightful discussion!
IQVIA Vice President for Clinical Operations Gjon Mirdita who oversees site management in the EMENA region shares his impressions on clinical operations from his recent visit to Egypt and Saudi Arabia, including the potential of clinical operations in these countries and the Middle East as a whole, IQVIA's work and cooperation with stakeholders in the region, and the development and growth of the teams and the individuals.
Elyse Munoz, IQVIA’s US Director of Research and Insights, joins the podcast to discuss insights from the second paper of a three-part series, all about optimizing a US launch. Expect to learn about what impacts the optimization phase of a US launch: patient adherence, market access in the US context (and how it’s different from Europe), and direct-to-consumer advertising (prohibited in other major markets).
IQVIA's Vice President for Tech & Services in the Middle East, Rauf Mohamed spoke with Johnson & Johnson Managing Director for Innovative Medicine in the Gulf Region, Pedro Matos Rosa about lung cancer in the region. Pedro and Rauf discussed the severity of lung cancer and its prevalence throughout the region, key stats and insights, the progress in the fight against this cancer, and the need for more initiatives in the region to help fight against lung cancer.
In 2023, the WHO and the World Bank recognized Egypt's remarkable achievement in eradicating hepatitis C. This podcast features a special guest, H.E. Dr. Mohamed Hassany, Assistant to the Minister of Health for Public Health and Presidential Initiatives in Egypt, who shares the nation's journey from having one of the highest incidence rates of hepatitis C to its successful elimination, and shares lessons and insights on how the strategy that was implemented can be adapted in other low- and middle-income countries.
In episode 8, IQVIA EMEA Thought Leaderships’ lead on patient engagement, Meike Madelung, joins the podcast to talk about why patient engagement and support services (PES) are important for launch. Hear examples of how PES can benefit patients, healthcare systems, and pharma companies striving for launch success.
This podcast episode explores how data-driven solutions are transforming the healthcare industry. Our guest is Bob Forcier, a key figure at Smith and Nephew who plays a pivotal role in leveraging data for operational improvements. Bob shares insights on how Smith and Nephew define operational efficiency and the critical role OneKey data plays in achieving it. He and OneKey’s Charles Wallace, Associate Director Product Offering, discusses the integration process, quantifiable metrics, and the benefits of using OneKey data. Listen to the podcast to learn about Smith and Nephew’s success story and how OneKey has streamlined their operations.
Featured speakers:
- Charles Wallace, OneKey Associate Director Product Offering, IQVIA
- Bob Forcier, Director, Smith and Nephew
Omnichannel is now a top priority for most pharma brand and commercial leaders. There’s a clear focus to embed omnichannel engagement and drive differentiating, consumer-like experiences within campaign plans and brand strategies. And while every organization is at a different maturity level, at IQVIA, we have seen a common trend that progress, regardless of your maturation, is harder and more limited than ever.
In this podcast, IQVIA’s Matthew Smith and Matthew Doyle host a roundtable discussion with Takeda’s Chris Weber, Head of Customer Experience, U.S. Oncology, Julia Allen, Product Marketing Director, from Fresenius Medical Care, and Eisai’s Jared Shechtman, Marketing Technology Solutions, who share their unique perspectives on where the pharma industry currently stands with omnichannel transformations, the challenges related to execution, and what’s needed to be more successful in 2024 and beyond.
In today’s complex healthcare landscape, understanding your customers is more challenging than ever, and as such, medical device and diagnostic line partners face significant gaps and unmet needs for their commercial teams. IQVIA’s latest solution, the MedTech Market Activator, fueled with OneKey data, empowers commercial teams with comprehensive insights and tools to support strategic growth and daily activities. Tune in to this podcast to learn from data and product experts about how the MedTech Market Activator will provide your teams the agility needed to make a greater impact.
Featured Speakers:
- Shauntell Kelley, Director of OneKey Product and Strategy, IQVIA
- Christian Brilliant, Director and Product Owner of MedTech Market Activator, IQVIA MedTech
- Harry Tomaszewski, Solutions Specialist, IQVIA MedTech
In episode 2, we examine financial assistance or case management: What is a case management approach and the importance of looking at the whole patient journey.
In this episode, we examine the needs of patients in the current health systems and the role and potential of patient support programs to improve patient access to reliable and innovative treatments.
Tune in as Paige Desmarais, IQVIA SFE Principal, and Ruoxin Li, IQVIA Sr Director in Advanced Analytics, delve into the transformative impact of AI and machine learning on healthcare analytics. In this episode, they explore how these technologies are reshaping provider referral patterns. As patient and provider journeys become increasingly complex, analytics managers and brand product managers seek innovative strategies to identify referral networks more effectively.
Clinical trials play a significant role in the development of drugs and medical breakthroughs. They are key for the advancement of medicine, although not all stakeholders are aware of their of their strong impact on patient care. Listen to our podcast with guest speaker Dr. Nawal Al-Kaabi Senior Advisor and Consultant, Pediatric Infectious Disease at Sheikh Khalifa Medical City who will walk us through the landscape of clinical trials in the UAE and the region, with a focus on the COVID-19 clinical trial program.
In this episode, Dr. Shelly Nash, Senior Vice President and Global Chief Medical Information Officer at Fresenius Medical Care, discusses the importance of health equity and access to care in driving better health outcomes. Dr. Nash defines the issue of health equity and shares initiatives and opportunities for medical device and diagnostic companies to accelerate progress and address hurdles along the way. Key highlights include the challenges of data integration and interoperability.
Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIA
Featured Speaker: Shelly Nash, DO, FACOOG, Senior Vice President, Global Chief Medical Information Officer, Fresenius Medical Care
IQVIA’s Vice President for Genomics and Precision Medicine Joanne Hackett discusses the importance of connected care, digital maturity, and innovation and technology in healthcare.
Learn about the progress and challenges facing the Expanded Program on Immunization in Nigeria.
In this episode, Sarah Rickwood and Stefan Lutzmayer discuss key findings from the “From Orphan to Opportunity: Mastering Rare Disease Launch Excellence” white paper. Discover how to navigate the complex rare disease landscape, overcome post-pandemic hurdles, and apply the three pillars of launch excellence to achieve success in rare diseases.
This episode focuses on Patient Centricity in Design and how engaging patients in protocol design can improve clinical outcomes. IQVIA’s Patient Centricity in Design solution helps sponsors optimize study design for patient engagement and patient outcomes, such as incorporating diverse patient preferences, selecting design elements that align with real-world patient experiences and using this knowledge to minimize patient burden. Ivan Petrov, Associate Design Analytics Director is our featured speaker.
Sarah Rickwood is joined by Elyse Muñoz, IQVIA’s US Director of Research & Insights, to discuss the first of a three-part launch excellence series on the current state of US launch and the new rules for launching excellently in the US, the most important market for global innovative medicines success.
Dive into the world of data management with “Consumer Health Edge” podcast’s latest episode, “Mastering Data; A Beginner’s Guide to Information Management.” Join host Vaishnavi Save as she welcomes Antonello Moscatelli, a seasoned expert with nearly two decades of experience in Data and Analytics. Together, they explore the crucial steps organizations must take to implement effective information management strategies. From aligning data strategy with business objectives to assessing the data landscape and ensuring security and compliance, this episode offers actionable insights and practical tips. Discover how to harness the power of data to drive informed decision-making, enhance efficiency, and gain a competitive edge in today’s dynamic market landscape. Tune in and empower your organization with the knowledge to unlock the full potential of your data assets.
Dr. Larisse Prinsen provides an overview of challenges, changes required, and implications of the NHI, from a legal perspective.
Rare Diseases, though individually uncommon, collectively affect a significant number of people. In the Middle East, these conditions present a unique set of challenges and opportunities. Tune into the final part of our podcast as we uncover how the Middle East is tackling these uncommon conditions and shed the light on what rare diseases mean to the region, from healthcare challenges to the latest advancements.
Rare Diseases, though individually uncommon, collectively affect a significant number of people. In the Middle East, these conditions present a unique set of challenges and opportunities. Tune into the first of our 2-part podcast as we uncover how the Middle East is tackling these uncommon conditions and shed the light on what rare diseases mean to the region, from healthcare challenges to the latest advancements.
In Episode 2 of our Consumer Health Edge podcast, Vaishnavi Save and Ankit Gupta delve into the dynamic world of data-driven customer journeys, sales, and distribution. We uncover the pivotal role of data analytics in optimizing shelf space for consumer health companies, suggesting how tools revolutionize in-store strategies. Understanding the consumer journey is paramount, with insights gathered from loyalty programs, social platforms, and primary market research. We explore the meticulous process of cleansing and storing data, essential for extracting actionable insights through diagnostic, descriptive, predictive, and prescriptive analytics. Moreover, we unravel the nuanced landscape of sales and distribution optimization, where data empowers companies to fine-tune their strategies, maximize revenue, and identify growth opportunities. Join us as we unravel the intricate web of data-driven healthcare strategies, offering a glimpse into the future of the industry.
Prof. Nicholas Crisp discusses South Africa's National Health Insurance, its potential, the reforms, changes, challenges, and the roles of the public and private sectors.
IQVIA invited Eric Grant, the Communications and Media Manager for the Union for International Cancer Control (UICC), to delve into the critical issue of the cancer care gap in low- and middle-income countries (LMICs) across the Middle East and Africa, shedding light on the challenges these countries encounter while striving to bridge this gap and the efforts being made.
Welcome back to IQVIA Digital Enablement’s podcast series: Personalization Science. This is part 2 of our conversation with Jason Patterson, Chief Analytics Officer at Publicis Health Media. This time, host Andrew Burkus, leads an insightful discussion on the future of measurement and optimization, the role AI may play in this evolution, and how all these elements will continue to drive better health outcomes. Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence
Prof. Roseanne Harris, Health Policy Actuary at Discovery Health, discusses South Africa's National Health Insurance, its potential, the reforms and changes, and the roles of the public and private sectors.
Welcome back to IQVIA Digital Enablement’s podcast series: Personalization Science. This week, we are joined by Jason Patterson, Chief Analytics Officer at Publicis Health Media, a top healthcare media agency built for the modern marketplace. In part 1 of this conversation, host Andrew Burkus and Jason dive into the world of healthcare media optimization, misconceptions in the industry, and how continuous optimization differs from campaign measurement.
Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence
IQVIA South Africa General Manager Sandri Yssel presents an overview of the South Africa National Health Insurance Program and the podcast series.
In the first episode of IQVIA Digital Enablement’s new podcast series, host Andrew Burkus, Sr. Principal, is joined by Amanda Powers-Han, Chief Marketing Officer at Greater Than One, a leading marketing communications agency dedicated to healthcare. Tune in as these industry experts define what personalization is, why it is essential for your audience engagement strategy, and how to drive better outcomes in healthcare and life sciences marketing. Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence
"Essentially, this allows our clinical researchers to improve the chances of success for the trial leading to faster, more efficient drug development… Ultimately, this is going to benefit patients.”
Greg Lever is speaking about the use of flexible modeling to allow real-time changes to be made to clinical trial design and processes.
As a director within the IQVIA Applied Data Science Center, and with over a dozen years of experience in the field, Greg knows the importance of data and advanced analytics in generating accurate patient insights to underpin key trial decision-making.
By making clinical trials more patient friendly, he states, the more likely it is that research organizations will be able to attract and retain the participants they need to bring life-saving treatments to patients.
In this podcast, Greg outlines how modeling can be used to enhance the entire patient journey, from the initial giving of informed consent right through to the trial’s close.
What if clinical trial sites could focus entirely on research? What if sponsors could have immediate access to trial patients during and after the study, and use those insights to improve trial design? What if all of that could be done without burdening an already strained site? What if those didn’t have to be “what ifs”?
In this sponsored episode of The Top Line, Julia Douthart talks to Jessica Jones, Director of Strategic Technology Delivery and Experience Optimization at IQVIA, about how new technologies are changing clinical trials, reducing the administrative burden on staff and improving insights for sponsors.
But can it be done without adding an additional technological burden and learning curve on the site staff? Listen below to learn how IQVIA is addressing these challenges.
In this episode, Sarah Rickwood and Kirstie Scott discuss key findings from the “Success Multiplied: Launch Excellence for Multi-Indication Assets” white paper. Learn about the specific challenges multi-indication assets face, such as sequencing and speed of indication roll-out, performance consistency across multiple indications and promotional investment strategies to capture pan-indication synergies.
In part two, Andrew Jones shares just how much data is available in IQVIA’s Infinite Dimension Profiler. Tune in and learn how you can build healthcare professional profiles that include both professional and personal dimensions. He also shares how the platform opens up data silos, relieving IT headaches, and allows you to build true omnichannel programs. If you missed part one, catch up for an overview of the Infinite Dimension Profiler.
Featured Speakers:
- Kathleen Aalderink, Director, OneKey Digital Enablement, IQVIA
- Andrew Jones, Product Manager, Global Information Management, IQVIA
Do you have a complete picture of the healthcare professionals (HCPs) in your universe? Are you able to dynamically target and message them as market events change? If you don’t, or even if you think you do, tune into this podcast where IQVIA’s Kathleen Aalderink and Andrew Jones discuss all things around joining and leveraging data to build and compare target audience profiles. You will hear how the Infinite Dimension Profiler will help you pinpoint the right HCPs, which in turn, increases the speed in which your therapies reach patients. Be sure to tune into part two; you’ll be impressed to hear about the incredible amount of data you can have at your fingertips.
Featured Speakers:
- Kathleen Aalderink, Director, OneKey Digital Enablement, IQVIA
- Andrew Jones, Product Manager, Global Information Management, IQVIA
This final episode focuses on the authority of physician assistants and naturopathic physicians. The conversation goes beyond the latest state-level authority regulations and includes a sampling of the varying definitions of what a naturopathic physician is. The speakers also share insight into what you can expect around prescriptive authority in the future. Be sure to tune into this episode, but to get the most out of our Prescriptive Authority series, take the opportunity to listen to parts one and two as well.
Featured Speakers:
- Shauntell Kelley, Associate Director, Digital Solutions Offering Management, IQVIA
- Liz Updike, Director & Sr. Managing Attorney U.S. Client Services, IQVIA
Dive into the world of data-driven healthcare in the inaugural episode of "Consumer Health Edge."
Join host Vaishnavi Save and industry expert Raj Jawalkar, with over two decades of experience, as we explore the game-changing role of predictive analytics.
Discover strategies for sustainable success, the importance of a well-defined business objective, and the critical pillars of data transformation. Raj unravels the complexities of sourcing, processing, and integrating data for effective predictive models.
Raj also provides insights into customer analysis for diverse industry groups—sales, pharmacies, marketing, and e-commerce. Learn how companies leverage predictive models to enhance effectiveness and drive strategic decisions in these domains.
This episode speaks about the foundations of successful predictive analytics, offering tangible examples and expert insights. Don't miss out on this engaging discussion that unveils the intricate world of data-driven healthcare and its transformative impact on sales and marketing.
Tune in now for a journey through the evolving landscape of consumer health!
Eric Klaver, DCT Regulatory Director, shares how IQVIA supports investigators within the areas of clinical trial conduct and operations.
IQVIA’s Head of Medical Affairs Strategy, Reinhard Berkels, joins Sarah Rickwood on the podcast to discuss the expanding role of Medical Affairs in launch. Hear how Medical Affairs is evolving and emerging as a more strategic function which can make or break a launch, and why this means companies should re-evaluate the way medical is positioned within their organization.
In Episode 3, Sarah Rickwood interviews Cristina Alzaga-Chaudhry, IQVIA’s EMEA Lead of Commercial Strategy & Transformation. Learn about agile launch planning, how launch performance management has evolved, and leading edge key performance indicators.
During part two of the prescriptive authority series, the discussion focuses on the legislation that is driving changes affecting optometrists and psychologists. Tune in to learn how the changes affect the type of data you should be leveraging to help insure you remain compliant.
Featured Speakers:
- Shauntell Kelley, Associate Director, Digital Solutions Offering Management, IQVIA
- Liz Updike, Director & Sr. Managing Attorney U.S. Client Services, IQVIA
AI for R&D: Episode 3 | Leveraging AI/ML to better predict an asset's success
Featured Speaker: Greg Lever, Director of R&D Solutions, Applied Data Science Center, IQVIA
Host: Susan Cokas
In this episode:
- See why integrating AI/ML into your operations will enable you to uncover deeper insights, make better informed clinical development decisions and realize competitive advantage
- Understand how AI-powered analytics can optimize your clinical development strategy
- Learn how data from different sources can be harmonized to provide a holistic view of a clinical development pathway and baseline success rates
Thank you for joining us for our leadership podcast around IQVIA’s Artificial Intelligence and advanced analytics for research and development. We look forward to sharing even more insights on how data science is being applied to augment and accelerate the R&D process in future episodes.
During this episode, IQVIA subject matter experts will share insights around the recent trends in prescriptive authority. Their conversation will be centered on the legislation driving the changes, what the changes are, why the changes are occurring, and how you can comply with the regulations.
Featured Speakers:
- Shauntell Kelley, Associate Director, Digital Solutions Offering Management, IQVIA
- Liz Updike, Director, Client Services, IQVIA
In this episode, Cal St. Denis, Global Director of Sustainability at Johnson & Johnson MedTech, discusses the importance of implementing sustainability agendas that build in sustainability initiatives and considerations at the front end in product design all the way through to packaging. Cal shares part of Johnson & Johnson’s sustainability journey and highlights how MedTech industry customers are evolving and now demanding insights into respective sustainability agendas.
Host: Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIA
Featured Speaker: Cal St. Denis, Global Director, Sustainability, Johnson & Johnson MedTech
In this episode, Cal St. Denis, Global Director of Sustainability at Johnson & Johnson MedTech, discusses the importance of implementing sustainability agendas that build in sustainability initiatives and considerations at the front end in product design all the way through to packaging. Cal shares part of Johnson & Johnson’s sustainability journey and highlights how MedTech industry customers are evolving and now demanding insights into respective sustainability agendas.
Host: Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIA
Featured Speaker: Cal St. Denis, Global Director, Sustainability, Johnson & Johnson MedTech
As life sciences companies continue to prioritize new, omnichannel-centric commercial and customer engagement models, the ability for small and emerging biopharma organizations (EBPs) to be nimble and agile (relative to larger pharma companies) presents a potential advantage. Because many of these organizations are not as constrained as some of their larger peers by the complexities of existing size and scale, there is an opportunity to develop these new models more quickly and effectively. However, to date, too few EBPs have truly excelled in this space. IQVIA’s Susan Kitlas, VP, Precommercial Team, and Frank Papaianni, VP, Small Pharma, join our host, Matthew Smith, Sr. Principal, New Commercial Models & Digital Health, to identify both leading practices and sensible first steps small and EBP organizations can take on their customer engagement model journeys in this episode of our Agile Brand Promotion podcast series.
This episode focuses on design analytics and how they can be used to assess study design decisions and identify risks prior to protocol approval. Knowing that a high number of protocols require at least one substantial, costly amendment— investing in optimizing your protocol upfront by applying design analytics is a great solution to reduce risk and ultimately increase the probability of success of your trial. Tammie Nguyen, Clinical Planning and Design Analytics Director is our featured speaker.
Sarah Rickwood and Kirstie Scott return in Episode 2 of the new Launch Excellence podcast series to discuss in more detail what companies should focus on in the challenging post-Pandemic environment. Expect to hear about the Three Pillars of post-Pandemic Launch Excellence and the elevated importance of healthcare system readiness to address the growing gap between the healthcare system preparation needs of many new launches and the ability of overstretched healthcare systems to meet those needs.
Sarah Rickwood and Kirstie Scott kick off the new Launch Excellence podcast series with a preview of their new white paper, Launch Excellence VIII. The authors discuss the evolving launch environment, post-Pandemic underperformance, resilient launches, and the latest insights on whether the "six-month window" holds in the challenging post-Pandemic environment.
Biopharma organizations are continuing to grow and invest in new customer-centric and omnichannel engagement models, and show no sign of slowing down. The pandemic has increased HCPs' digital maturity and comfort levels, while accelerating life sciences companies’ investment in and adoption of digital and virtual channels. HCPs now want more choice and flexibility regarding when, where, and how organizations interact with them. In this podcast, IQVIA’s host, Matthew Smith, Sr. Principal, New Commercial Models & Digital Health, is joined by Arooba Marks, Customer Experience Lead at Pfizer Connect, Rich Palizzolo, Executive Director, Customer Experience at Sobi North America, and Alison Tapia, Sr. Director, Performance Marketing and Digital Innovation at Dermavant, to discuss and explore some of the common challenges and pitfalls companies face, lessons learned, and insights from efforts in the market. Other key topics include what’s working, keys to success going forward, and other industry perspectives from various functional domains.
In this episode, we will discuss how the specialty and rare disease ecosystems are evolving with new modes of care delivery, patient-centric programming, and expanding data sources.
In part one, we will talk specifically about barriers to patient access and brand strategies to overcome these challenges and share a well-rounded view of the current specialty and rare disease environments. Joining IQVIA’s Hari Rayapudi is an incredibly talented group of industry leaders in specialty patient care for broad, specialty, and rare disease brands.
Featured speakers:
- Hari Rayapudi, Senior Principal, Specialty Data Strategy and Consulting Services, IQVIA
- Jourdan Masullo, Sr. Director, Patient Services, Kyowa Kirin
- Natasha Mayfield, General Manager, Optum Frontier Therapies
- Jessica Mourani, Director, Clinical Outcomes, Trellis Rx
- Umang Thaker, Director, PSS Oncology Strategy & Management, Novartis
IQVIA’s Hari Rayapudi and a group of guest speakers are back for part two. They will be sharing their perspectives around the challenges and interpreting specialty and rare disease data to ensure that there is alignment on insights. We will discuss technical challenges, systems platforms, and standards.
Featured speakers:
- Hari Rayapudi, Senior Principal, Specialty Data Strategy and Consulting Services, IQVIA
- Jourdan Masullo, Sr. Director, Patient Services, Kyowa Kirin
- Natasha Mayfield, General Manager, Optum Frontier Therapies
- Jessica Mourani, Director, Clinical Outcomes, Trellis Rx
- Umang Thaker, Director, PSS Oncology Strategy & Management, Novartis
In this episode, industry experts from IQVIA and Databricks talk about common information management challenges and opportunities for life sciences organizations to streamline their approach to data pipeline management and accelerate drug development and delivery as they undergo the necessary transformation modern healthcare demands. We will discuss how our partnership with Databricks can enable faster data ingestion, quicker time-to-insights, and cost reductions, as well as highlight success stories of companies who have already simplified their data governance and improved patient outcomes.
Speakers:
Bill Zanine
Practice Leader Data Warehousing & Data Science, IQVIA
Michael Sanky
Global Industry Lead for Healthcare & Life Sciences, Databricks
Katie Laughlin
Global Head, Offerings Human Data Science Cloud, IQVIA
In episode two, IQVIA subject matter experts from the Channel and Specialty Data Services and Compliance teams will address a group of frequently asked questions around the topic of Suspicious Order Monitoring (SOM) and share some of their insights and real experiences. If you missed episode one, tune in to hear the team talk about Title 21 CFR 1301, the importance of size, patterns and frequencies, and how to use the appropriate and proper data. Plus, the tools that exist to help you stay compliant.
Featured speakers:
- Heather Kinney, Director, Offerings Management, IQVIA
- Paul Hamby, Senior Director, U.S. Regulatory Compliance Solutions, IQVIA
- Kim Randolph, Associate Director, Product Management, IQVIA
- Eric Brantley, SOM Engagement Manager, IQVIA
In this episode, IQVIA Channel and Specialty subject matter experts with members of IQVIA’s Compliance team discuss Suspicious Order Monitoring (SOM). Their conversation focuses on how, in recent years, laws have expanded, adding new legal requirements necessitating existing processes to adapt for manufacturers and distributors to remain compliant while distributing controlled substances. Listen in to gain a better understanding of the updated legislation, new requirements, and supportive data and existing tools that can help you stay compliant.
Featured speakers:
- Heather Kinney, Director, Offerings Management, IQVIA
- Paul Hamby, Senior Director, U.S. Regulatory Compliance Solutions, IQVIA
- Kim Randolph, Associate Director, Product Management, IQVIA
- Eric Brantley, SOM Engagement Manager, IQVIA
The launch environment has shifted significantly in the past few years, as it is increasingly more difficult and expensive to reach prescribers. While evolving challenges, including changes in the relative importance of launch stakeholders and the rise in patient-centricity, accelerated due to COVID-19. Although face-to-face interactions between sales representatives and healthcare professionals remain a core tenant of a brand's marketing and sales strategy, omnichannel promotion is growing in importance. As the healthcare ecosystem settles into a new equilibrium, the definition of success has shifted.
In this episode of our Agile Brand Promotion podcast series, Nadine Vangelov, Sr. Principal, Launch Center of Excellence, and Daniel Luft, Sr. Principal, Brand & Commercial Strategy, join our host, Matthew Smith, Sr. Principal, New Commercial Models & Digital Health, to discuss how the success criteria for launch have evolved, how to define and prepare for success in this new era, and then explore how to enable more agility within and beyond the crucial first months of launch.
Our host, Matthew Smith, Sr. Principal, New Commercial Models & Digital Health, IQVIA, is joined by Madhavi Ramakrishna, Global VP of Cx, Data, Digital and Omnichannel at GSK, and Indraneel Mukherjee, a Sr. Principal in IQVIA’s strategy consulting group, to explore the future of customer experience and omnichannel for biopharma. In this episode, our experts dive into the reasons why during the pandemic, most biopharma organizations invested significantly in their virtual and digital marketing channels, systems, and technologies – many instances trying to scale them almost overnight. They discuss that most companies recognize this as a priority and have programs in flight to modernize their ecosystems, generate the necessary customer insights, and upskill their people to be able to “deliver omnichannel.” Most importantly, the panel looks into the future (5+ years from today) – where do we want to be and what needs to be true to get there?
In this episode of our Agile Brand Promotion podcast series, IQVIA’s Christie Conn, VP, Brand & Commercial Strategy, Jave Castillo, VP, CSO Strategic Solutions, and Kirk Harmon, VP, Contract Sales, join our host, Matthew Smith, Senior Principal, New Commercial Models & Digital Health, for an in-depth panel discussion on Agile Deployment for Modern HCP Engagement. In this podcast, our experts explore the various ways in which commercial pharma leaders are looking to balance innovative specialty launches with their existing revenue generators in an increasingly pressured access environment. Additionally, the panel discusses how, with today’s demands, it’s critical that commercial pharma leaders ensure that their biggest investments – field teams – are enabled to deliver the right message, at the right time, to the right customer, in order to keep HCPs engaged.
Creating a smart data strategy, with streamlined data collection and compliant reporting, requires strategic solutions that are automated, flexible, and fit-for-purpose. Selecting a device that fits both a trial and a data strategy can present a challenge for sponsors. Learn more by listening to this podcast from IQVIA leader Jacinta Rodrigues.
Digital Health Technologies are becoming crucial as clinical trials become more patient centric, but they pose challenges that must be considered.
Today, the clinical trial operations industry is experiencing exponential growth in the use of devices, however, making sure these devices are optimized for trial use poses some challenges. In this podcast with Mike Bruhns, Director of Supplier Services from IQVIA, discover why it is important to find a device that meets the needs of a clinical trial.
In this episode, join the Analytics Insights and Reporting (AIR) team as they discuss their participation in the recent Gartner Conference. Gartner is a consulting organization that conducts research on technology and then shares the results through both private consulting and executive-level programs and conferences. The AIR team will share their insights and takeaways from the three-day event and review how IQVIA can leverage key themes to better enable data and analytics within healthcare life science organizations.
Featured Speakers:
- John F. Jackowski III, MBA LSSGB, Product Owner, Analytics, Insights, and Reporting, IQVIA
- Marlin Strand, Principal, Enterprise Business Intelligence, Analytics, Insights, and Reporting, IQVIA
- Andy Barnes, Principal and Commercial Analytics Consultant, Analytics, Insights, and Reporting, IQVIA
In this episode, we continue the discussion of product data management and include details around what type of product data management system may be the best fit for your organizational needs. We also focus on the types of problems that can be alleviated with each type of system, how the systems can complement each other, and why it is acceptable to have more than one type of system deployed to fully address your business and technical requirements.
Featured Speakers:
- Jay Dzwil, Director and Solution Architect, IQVIA
- Michael Selvaggio, Technology Principal and Solution Architect, IQVIA
In this episode, Catherine Ellis and Raj Stewart of the IQVIA MedTech Commercial Consulting Team discuss a selection of key trends impacting the U.S. MedTech industry today. Take a deeper dive into the drivers of the recent direct-to-consumer advertising growth, hear how market access trends are going to impact the diagnostics market, and learn how labor shortages in healthcare are driving MedTech companies to innovate.
Read Ten MedTech Trends to Watch in 2023 to learn more.
Host: Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIA
Featured Speakers:Catherine Ellis, VP, Practice Lead, U.S. MedTech Consulting, IQVIA
Raj Stewart, Principal, MedTech Market Access, IQVIA
In this episode, we discuss current trends in the data governance space for the life sciences industry, focusing on changes in the last 12-24 months on how companies are approaching management of their critical data assets with a more structured methodology. We also speak on how critical it is to manage your data correctly, the business processes tied to the data, and the potential to leverage data intelligence platforms to support this effort.
Featured Speakers:
- Jay Dzwil, Director and Solution Architect, IQVIA
- Phyllis Imparo, Practice leader, Data Stewardship, IQVIA
Part two of the product data management discussion covers the challenges of globalization and hierarchy management that are frequently encountered by life sciences organizations, and how a product data management solution can be used to alleviate many of them. The goal is to help listeners become better versed in what an optimal product data management solution can mean for their organization.
Featured Speakers:
- Jay Dzwil, Director and Solution Architect, IQVIA
- Michael Selvaggio, Technology Principal and Solution Architect, IQVIA
Over the past several years, there’s been a marked increase in the volume of emerging biopharma (EBP) companies facilitating their own product launches. In today’s turbulent market, one of the ways that EBP leaders can make a difference in their launch success is focusing on investment optimization – making sure that they’re smart about how their limited resources (digital, field-force, etc.) are deployed. In this episode of our ongoing podcast series, Agile Brand Promotion for the Emerging Biopharma Market, Susan Kitlas VP, Precommercial Segment, joins our host, Matthew Smith, Sr. Principal, Consulting Services, for an in-depth discussion on new commercial models for the EBP market.
In this episode, we begin part one of a product data management discussion to clear up some common misconceptions around various technologies (and their assorted acronyms) to help users become better versed in what optimal product data management can mean to their life sciences organization. This episode will better define what is meant by ‘the product,’ dig into the most frequently used data management technologies, and help clarify the role that each technology plays in the overall data management process.
Featured Speakers:
- Jay Dzwil, Director and Solution Architect, IQVIA
- Michael Selvaggio, Technology Principal and Solution Architect, IQVIA
In this episode, Peter Bennett, Senior VP of Global Planning at Cardinal Health, discusses key components required to build a supply chain resiliency framework, the need for transparency and collaboration between MedTech product suppliers and distributors, the role of enhanced scorecards, and new approaches to demand planning/forecasting during times of uncertainty.
Host: Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIA
Featured Speaker: Peter Bennett, CPIM, Senior VP of Global Planning, Cardinal Health
Nathan Sommerford, Global Lead of AI for Drug Discovery & Development at IQVIA, discusses how AI/ML is disrupting R&D across the board.
In this episode:
- How working in synergy with clinicians and research scientists, AI/ML can provide a much-needed augmentation to how drugs are developed.
- Understand where to apply AI, whether it's early in drug discovery, to find the right patient subpopulations or to do disease modeling.
- Explore using a machine learning approach based on fairness ranking systems to best represent a clinical trial patient base and address the challenge of diversity and inclusion.
In this episode of the series “Selfcare Evolution”, IQVIA’s Omid Ashrafi is in conversation with everyday consumers to discuss their shift in shopping behavior pre and post COVID-19. Tune in to this exciting conversation to find out how consumers from across the Middle East are now shopping for OTC products. Get in touch with us here to learn more.
Our host, Matthew Smith, Senior Principal, Consulting Services, is joined by guests, Kelly Peters, Vice President, Marketing Center of Excellence, Andrew Burkus, Senior Principal, Client Success, Omnichannel Marketing, and Kristen Winters, Director, Pharma Digital Enablement, as they kick off their conversation by discussing what major challenges commercial pharma is facing as it relates to HCP engagement and how comprehensive, connected HCP data can provide solutions. Additionally, the panel explores the importance of campaign measurement, and how it goes hand-in-hand with campaign optimization, toward the goal of “continuous improvement,” both in terms of personal (face-to-face sales) and non-personal (digital) outreach efforts.
In the past, patient-level insights were achieved through time-consuming methods requiring substantial manual effort to produce static reports. With the help of technology and machine learning, that’s no longer the case. Dynamic reports and dashboards can provide faster answers to questions that go beyond the original report, while also allowing team members to ask their own questions. With dynamic reports, team members can share information freely without the manual drag of pulling data or static reports and performing manual queries to get what they need.
Join Andy Burch and Brian Smith, two thought leaders with a breadth of experience in AI-ML solutions, as they dive into the benefits of bringing automated data into dynamic visualization products and how they can help you develop deeper insights, faster, while improving team engagement.
Brian and Andy outline several ways dynamic reports are superior to static reports, even helping to foster a data-driven culture. Knowing at your organisation who is asking the questions about your brand performance, patient profiles, or key physicians in your market, when are they asking the questions, how up to date does the data need to be? All this can feed into a highly customised dynamic delivery rather than only being able to ask questions once in a static delivery model.
Real world data (RWD) and artificial intelligence (AI) offer an unprecedented opportunity for Medical Affairs professionals to understand and share deeper insights about patients, including insights regarding disease progression, outcomes, and treatment response, as well as additional insights about patients’ journeys prior to diagnosis and after treatment initiation.
Cindy Weber of IQVIA’s Artificial Intelligence Solutions team explains how embracing RWD and AI technology, and the opportunities they provide, is helping to transform Medical Affairs, making it more impactful. By leveraging new insights, Medical Affairs professionals can foster better, more meaningful, connections with healthcare professionals, while also making important new contributions to improving patient care. Cindy provides specific examples of the kinds of insights AI and RWD are providing today and makes specific suggestions for how your Medical Affairs team can move forward in this new, exciting direction.
On this short taster for an upcoming IQVIA Consumer Health webinar, The Next Wave of Self-Care Digital Health, Dr. Volker Spitzer and Swapna Kondapuram discuss how the consumer health industry can apply digital health technologies, the most relevant areas the industry should be paying attention to, and where they think the value in investing in digital health really lies. They then close off the session by taking a look into the future of digital health.
In 2020, scientists working on injury analytics expanded to COVID-19 epidemiology to help create and monitor the NBA bubble. Dr. Christina Mack, an epidemiologist with IQVIA Real World Solutions, talks with Dr. Josh Sharfstein about how the team continues to monitor the health and safety of players and staff, and some of the findings with real-world implications such as how long people can shed COVID-19 virus, if people with asymptomatic infections are less likely to transmit COVID, and whether boosters really work.
In this episode of the series “Selfcare Evolution”, IQVIA’s Adhiti Kumar is in conversation with Ahmed Elsayyad to discuss the impact of private labels on the OTC market. Get insights about the evolution of the OTC market in Saudi Arabia and learn more about the key growth drivers and challenges seen in the private label market. Get in touch with us here to learn more.
In this episode, Shannon Haymond, President of the American Association of Clinical Chemistry (AACC), discusses the highlights from the AACC Annual Scientific Meeting & Clinical Lab Expo held in Chicago, IL.
Featured Speakers:Shannon Haymond, President, American Association of Clinical Chemistry (AACC), Laboratory Director at the Ann and Robert H. Lurie Children’s Hospital of Chicago, and Associate Professor of Pathology at Northwestern University, Feinberg School of Medicine Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIA
In this episode, Lena Chaihorsky, Co-Founder and VP of Payer Innovation at Alva10, and Michaela Miller, Practice Lead, Technology & Analytics at IQVIA, discuss value-based pricing in in vitro diagnostics.
Featured Speakers:Lena Chaihorsky, Co-Founder and VP of Payer Innovation, Alva10
Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIA
In this episode of the series “Selfcare Evolution”, IQVIA’s Adhiti Kumar is in conversation with Mearal Hussien to discuss the economic changes and the regulatory pricing changes that took place in MENA and their impacts on the OTC market. We will highlight how multiple factors, such as an increase in supply chain is affecting the current economic situation and what companies are doing to address this. We will deep dive into the nature of the OTC industry and the steps they are taking to stabilize their market. Get in touch with us here to learn more.
In this episode of the series “Selfcare Evolution”, IQVIA’s Sneha Keshav is in conversation with Dr. Sabih Shaikh*, to discuss the effect of the radical shift in consumer health companies and their adoption of a ‘Digital First Approach’ in their engagement with HCPs and patients. We will highlight how one of the leading consumer health companies made this shift while incorporating an omni-channel approach as a new way of working. We will also learn how success is defined and what are the key enablers of this. Get in touch with us here to learn more.
*Dr. Sabih Shaikh was part of Johnson and Johnson when this podcast was recorded.
Communication has always been critical in the process of brand building as such in any industry, and it is becoming even more relevant in Consumer Health considering the increased exposure and reliance on self-medication. In this episode of Fostering Consumer Health, we will be talking to a very passionate brand builder and an experienced business leader, Ritu Mittal, who heads Marketing and Digital for Bayer Consumer Health and has played a pivotal role in giving a new life to a legendary brand like Saridon and further nurturing a growing brand like Supradyn. Tune in to this interesting conversation, where Ritu shares her perspective on healthcare consumerism, foundational pillars of consumerism and critical success factors behind Bayer Consumer Health’s recent successes and more to come.
In this episode of the series – The Self-care Evolution, IQVIA’s Consumer health expert, Omid Ashrafi, is in conversation with Dr. Mohamed Galal, Vice President - Head of Middle East, Bayer Consumer Health to discuss how the pandemic has led to a change in consumer buying behavior and has accelerated the adoption of newer channels. He also speaks about how the industry is shaping up to cater to consumer’s channel needs and regional challenges that the companies need to be cautious of while devising channel strategy.
Current methods of making decisions on drug assets are becoming antiquated, costing a lot of time...money...and unnecessary risk. Understanding the probability of technical and regulatory success (PTRS) for a given indication enables faster, smarter decisions while minimizing risk. Learn about the new Asset Intelligence tool, which validates R&D candidates through powerful AI-driven analysis and real-world data to forecast clinical trial outcomes, in this podcast.
During this episode, the team digs into the hot topic of 340B. For many organizations, 340B has a negative impact on their Gross to Net. Tune in and learn about the effect discount stacking has on product pricing and service fees that are paid to specialty pharmacies and wholesalers. All effect your Gross to Net profit and calculations.
In episode one, we share information about the general environment around Gross to Net, the impact it has on your business, and how to help maximize it for organization efficiency and profitability. Plus, insights for collecting and integrating together all the necessary data.
Yes, Gross to Net is big! During this wrap-up session, we introduce rebate exclusions, anti-kickback statutes, and financial SOX compliance controls into the conversation. The team sheds light on data integration as critical in pulling all the data together and pushing the analytics to the right people across your organization. Plus a few thoughts on the future of Gross to Net and how leveraging newer technology will help to build an even clear picture.
In this episode, we discuss digital twin technology and the value of computational modeling in healthcare with Dr. Steve Levine, Sr. Director of Virtual Human Modeling at Dassault Systèmes, and Founder of The Living Heart Project.
Digital transformation has always been widespread but with the COVID-19 pandemic, accelerated adoption of digital and remote capabilities such as self-tracking medical devices, virtual clinical trials and telemedicine have become more prevalent. Listen to the podcast to hear from IQVIA MedTech and Digital experts on the current industry trends, how MedTech companies can build their strategic roadmap to leverage their own digital capabilities in order to achieve digital maturity and successfully transform in this era and beyond.
To learn more about digital transformation in MedTech, download our white paper here.
While FMCG has been the early adopter of Digital Prowess, the pandemic has pressured many sectors to scale up their digital marketing capabilities, including consumer health brands. In this Episode of ‘Going the Digital Way’, IQVIA’s Consumer health expert Tina Khadloya is in conversation with Vijayaraghavan Venugopal, Co-founder and CEO of FAST & UP, who has been one of the early adopters of Digital Wave for a consumer health brand. Tune in to listen and understand why digital is even more relevant for consumer health and how to surf through this wave differently.
The promising technique of drug repurposing is gaining attention from across the pharma industry, not only for reducing time and cost, but also lowering risk in the process of developing drugs for cancers and other rare illnesses — ultimately getting life-saving treatments to patients faster. Nathan Sommerford, Global Lead of AI for Drug Discovery & Development at IQVIA, discusses the basics of drug repurposing and how this approach is rapidly expanding in this latest podcast.
In this episode, Navin Dewagan, President of Digital Health Solutions, and Michaela Miller, Practice Lead, Technology & Analytics at IQVIA discuss the importance of cybersecurity in the medical device space. Learn about the latest FDA guidance and how to incorporate cybersecurity into medical device management and product development strategies.
Often described as game-changing, artificial intelligence and machine learning technology is revolutionizing drug development and the pharmaceutical industry. See how you can leverage AI/ML to mine old drugs for new applications and bring treatments to patients faster – at lower costs – in this Leadership Podcast.
In this episode, we hear from Catherine Ellis, Vice President and Leader of IQVIA’s U.S. MedTech Consulting Practice, as she describes some of the key global trends in the MedTech industry today. Hear how she describes which trends will have the biggest impact and where we can expect to see changes.
Learn more at: https://www.iqvia.com/locations/united-states/blogs/2022/01/ten-medtech-trends-to-watch-in-2022
In Episode 4 of “Through the Biotech Lens: Molecule to Market" Nagaraja Srivatsan, Chief Digital Officer, R&DS Technology Solutions and Yumi Inadome, Associate Sales Engineer Director will explain the different benefits digital can contribute to the clinical trial journey.
Episode 3 of "Through the Biotech Lens: Molecule to Market" features Jerome Armellini and Dr. Craig Underhill as they delve into how the COVID-19 pandemic has accelerated the adoption of decentralized clinical trials. Learn about the benefits of these decentralized trials and how IQVIA's technology platforms brings the decentralized solution to life and benefits patients directly.
In episode 2 of our mini-podcast series "Through the Biotech Lens: Molecule to Market", our speakers David Cameron, Senior Director and Global Head of Novel Trial Design and Lucas Glass, Vice-President of Artificial Intelligence will discuss innovative trial designs that bring together the best of biopharma and technology to bring value to the patient.
As clinical trial sponsors face increasing pressure to deliver new treatments to market faster, connected digital medical devices are taking on a larger and more critical role. In this podcast, Connected Devices leader Jeff Noll from IQVIA will discuss how to simplify and accelerate data collection for your clinical trials with expert medical device selection and a smart data strategy.
This podcast will discuss how to create a strategy for-
- Better devices—for your study protocol and endpoint strategy
- Better data—streamlined collection and compliant reporting
- Better solutions—flexible service and support options to match your needs and priorities
We are pleased to introduce the mini podcast series, Through the Biotech Lens: Molecule to Market, for emerging biopharma and biotech. In episode 1, Patrice Hugo, Chief Scientific Officer of Q2 Solutions and Angela Gong, Director of Global Regulatory Affairs will discuss useful tips for biomarker selection and successful Investigational New Drug submission.
In this podcast, IQVIA experts Sarah Rickwood and Natalie Harb dig deeper into the issues and solutions that drove post-pandemic launches in 2020. In addition, the hosts explore the challenges that remain for innovative launches in 2021 and what can be done by companies aiming to launch products post the pandemic.
As real world evidence is becoming increasingly accepted by the regulators, the need for fast, flexible, and cost-efficient real world data has become more apparent. Hear leaders from IQVIA discuss the challenges and solutions to identifying and accessing the most appropriate data sources.
In Episode 1, IQVIA experts explore a new segment of patients that have emerged as a result of this pandemic.
Description: In this episode, Hannah Law, Head of U.S. Thought Leadership and Communications, shares how COVID-19 has shaped the way she embodies leadership and how she fosters her team. Hannah also details three pieces of advice she feels are important for the next generation of women in life sciences to keep in mind.
Featured Speaker: Hannah Law, Head of U.S. Thought Leadership and Communications
Description: Real World Evidence Site Manager, Chetana Khan, shares her experiences working with IQVIA and highlights some major wins she’s passionately worked towards achieving. Hear how she pulls inspiration from her daily life which acts as foundation for her professional life.
Featured Speaker: Chetana Khan, Real World Evidence Site Manager at IQVIA
Description: Prithvi Addepalli, MHA, Consultant, Strategic Consulting, Patient Centered Solutions at IQVIA, shares the ways in which she plans to take on calling out gender bias and inequality in 2021. She also discusses how working with IQVIA has changed her, and her advice for the next generation of women in healthcare.
Featured Speaker: Prithvi Addepalli, MHA, Consultant, Strategic Consulting, Patient Centered Solutions at IQVIA
Description: Jimena Martinez, Associate Director Global Clinical Quality Management, discusses what inspires her and how she plans to personally call out gender bias and inequality in 2021. We also hear how her experience working in life sciences has changed her.
Featured Speaker: Jimena Martinez, Associate Director Global Clinical Quality Management at IQVIA
Description: IQVIA’s Lisa Scibetta-Bruce, Manager in U.S. Marketing, discusses how her career has evolved and where she sees herself in the future. Listen as she gives advice to the next generation of women working in healthcare in terms of what they should or shouldn’t do to pursue leadership positions.
Featured Speaker: Lisa Scibetta-Bruce, Manager in U.S. Marketing
In this episode, we hear from Lisa Stockwell Morris, VP & GM of U.S. Real World Solutions at IQVIA, about her experience working with IQVIA and how the challenges she’s experienced have shaped her. We hear from Lisa how she would advise the next generation of women working in healthcare and the importance for personal and professional evolution.
Featured Speaker: Lisa Stockwell Morris, VP & GM of U.S. Real World Solutions at IQVIA
In this episode, we hear from Nandini Selvam, VP & GM of IQVIA Government Solutions, as she describes what has been some highlights in her career before and during her time with IQVIA. Hear how she expects the COVID-19 pandemic will shape the way the next generation of women in leadership go about creating change.
Featured Speaker: Nandini Selvam, VP & GM of IQVIA Government Solutions
The healthcare ecosystem has shown incredible resilience and an impressive appetite for adaption as we continue to live through the COVID-19 pandemic. This is especially true for clinical trials which have been maintained through innovation and the efforts of teams on the ground. Listen to hear the real-life experiences and strategy for managing a complex COVID-19 clinical trial from two of IQVIA's Clinical Project Managers.
Host: Ken Lee, Chief Medical Officer, IQVIA Asia Pacific
Feature Speakers: Cyril Vincent, Senior Clinical Project Manager, IQVIA Asia Pacific
Sarah Woodward, Clinical Project Manager, IQVIA Asia Pacific
In an era where every healthcare organization has a digital mandate, what does it take to be "digital forward thinking"? Listen to learn what it takes to implement a digital mandate and create true value for the end user.
Host: Ruthie Burr, Strategic Marketing Consultant, APAC
Featured Speaker: Swapna Kondapuram, Director, Regional HQ Clinical & Real World Evidence, IQVIA Consumer Health
Nicholas Mageras, Principal, Digital Strategy Lead, IQVIA Technologies
As virtual tools become more ingrained in our personal and professional lives, what will this mean for virtual Real World Evidence (RWE) in Consumer Health? Listen to learn about RWE, Consumer Insights in a self-care reality.
Host: Ruthie Burr, Strategic Marketing Consultant, APAC
Feature Speakers: Swapna Kondapuram, Director, Regional HQ Clinical & Real World Evidence, IQVIA Consumer Health
Dr. Pranab Kalita, Global medical affairs Respiratory & Skin Health, GSK Consumer Healthcare
Welcome to the Human Data Scientist, a series about what we don't know in healthcare and how we can know more. Join us as we chat with industry leaders on how medicine and data science, when brought together in the right way, can achieve something remarkable.
Host: Hannah Law, Head of Enterprise Content, IQVIA
What is Human Data Science? Listen for a Human Data Science 101 and learn why this familiar sounding term is essential to better understanding COVID-19 and preventing future disease outbreaks.
Host: Hannah Law, Head of Enterprise Content, IQVIA
Feature speaker: Murray Aitken, Executive Director, IQVIA Institute for Human Data Science
In the second episode of a two-part series, explore two low-impact scenarios for a post-COVID-19 world, Journey Disrupted and Reputation Reborn.
Journey Disrupted: Plansbased on a coordinated national-level healthcare policy that would limit surges in COVID-19 infections and accelerate the reopening of non-urban areas in some states.
Reputation Reborn: Plans based on the idea that the virus would subside or be “under control” by mid-2021 due to effective disease management and therapies.
To explore the two high-impact scenarios, listen to Scenario planning for a post COVID-19 world (Ep. 1)
Featured speaker: Mason Tenaglia, Vice President, Thought Leadership, IQVIA
COVID-19 will have a lasting impact on U.S. business and care delivery models. In a two-episode series, explore four different scenarios for a post COVID-19 world. In the first of two episodes, learn about the exercise conducted to develop the four scenarios and explore the two high-impact scenarios, The Long Night and Too Many Moving Parts.
The Long Night: Plans for high impact in the U.S. that would continue beyond the next 18 months with no effective disease management before 2022.
Too Many Moving Parts: Plans based on the assumption that some COVID-19 impact continues for 18 months or more, but that management options exist for vulnerable or high-priority populations.
To explore the two low-impact scenarios, listen to Scenario planning for a post COVID-19 world (part 2)
Featured speaker: Mason Tenaglia, Vice President, Thought Leadership, IQVIA